Detalles de la búsqueda
1.
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label study.
Am J Hematol
; 98(11): 1742-1750, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37647123
2.
Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin.
Blood
; 131(12): 1325-1336, 2018 03 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29437589
3.
PD-L1 over-expression is driven by B-cell receptor signaling in diffuse large B-cell lymphoma.
Lab Invest
; 99(10): 1418-1427, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31197205
4.
Integrative analysis of PD-L1 DNA status, mRNA status and protein status, and their clinicopathological correlation, in diffuse large B-cell lymphoma.
Histopathology
; 74(4): 618-628, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30286249
5.
Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B-cell lymphoma.
J Pathol
; 246(2): 141-153, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29876933
6.
Interdigitating dendritic cell sarcoma: Clinicopathologic study of 8 cases with review of the literature.
Ann Diagn Pathol
; 34: 155-160, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29660568
7.
MYC protein dysregulation is driven by BCR-PI3K signalling in diffuse large B-cell lymphoma.
Histopathology
; 71(5): 778-785, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28639315
8.
DIXDC1 activates the Wnt signaling pathway and promotes gastric cancer cell invasion and metastasis.
Mol Carcinog
; 55(4): 397-408, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25648220
9.
Upregulated expression of DIXDC1 in intestinal-type gastric carcinoma: co-localization with ß-catenin and correlation with poor prognosis.
Cancer Cell Int
; 15: 120, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26689843
10.
Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma.
J Transl Med
; 12: 10, 2014 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24418330
11.
[Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].
Zhonghua Bing Li Xue Za Zhi
; 43(5): 307-12, 2014 May.
Artículo
en Zh
| MEDLINE | ID: mdl-25030862
12.
GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma.
Cancer Biol Ther
; 23(1): 369-377, 2022 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35491899
13.
The epigenetic silencing of microRNA-433 facilitates the malignant phenotypes of non-small cell lung cancer by targeting CREB1.
Am J Transl Res
; 13(11): 12302-12317, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34956454
14.
Alteration of Cholesterol Metabolism by Metformin Is Associated With Improved Outcome in Type II Diabetic Patients With Diffuse Large B-Cell Lymphoma.
Front Oncol
; 11: 608238, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34195068
15.
Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2.
Blood Adv
; 5(1): 185-197, 2021 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33570628
16.
Cell-of-Origin Subtyping of Diffuse Large B-Cell Lymphoma by Using a qPCR-based Gene Expression Assay on Formalin-Fixed Paraffin-Embedded Tissues.
Front Oncol
; 10: 803, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32582543
17.
Diffuse large B-cell lymphoma with low 18F-fluorodeoxyglucose avidity features silent B-cell receptor signaling.
Leuk Lymphoma
; 61(6): 1364-1371, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32090646
18.
EBV-positive diffuse large B-cell lymphoma features PD-L1 protein but not mRNA overexpression.
Pathology
; 50(7): 725-729, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30389217
19.
Primary breast diffuse large B-cell lymphoma: a population-based study from 1975 to 2014.
Oncotarget
; 9(3): 3956-3967, 2018 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29423097
20.
XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB.
Mol Cancer Ther
; 17(12): 2564-2574, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30510142